Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.39 - $42.1 $899,593 - $1.49 Million
35,431 Added 25.6%
173,840 $7.31 Million
Q1 2024

May 15, 2024

SELL
$27.44 - $35.56 $25,738 - $33,355
-938 Reduced 0.67%
138,409 $4.06 Million
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $2.57 Million - $3.48 Million
-90,435 Reduced 39.36%
139,347 $5.07 Million
Q3 2023

Nov 14, 2023

SELL
$28.28 - $38.36 $1.8 Million - $2.44 Million
-63,577 Reduced 21.67%
229,782 $7.37 Million
Q2 2023

Aug 14, 2023

BUY
$17.67 - $31.31 $3.6 Million - $6.38 Million
203,832 Added 227.68%
293,359 $9.19 Million
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $1.53 Million - $3.45 Million
89,527 New
89,527 $2.04 Million
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $2.22 Million - $2.96 Million
-51,351 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $298,478 - $340,988
-5,653 Reduced 9.92%
51,351 $2.86 Million
Q2 2021

Aug 16, 2021

SELL
$51.29 - $59.15 $2.16 Million - $2.49 Million
-42,085 Reduced 42.47%
57,004 $3.09 Million
Q1 2021

May 14, 2021

BUY
$42.18 - $56.07 $1.13 Million - $1.5 Million
26,831 Added 37.13%
99,089 $5.56 Million
Q4 2020

Feb 12, 2021

SELL
$35.18 - $43.52 $992,498 - $1.23 Million
-28,212 Reduced 28.08%
72,258 $3.15 Million
Q3 2020

Nov 16, 2020

BUY
$37.98 - $48.72 $531 - $682
14 Added 0.01%
100,470 $3.91 Million
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $1.68 Million - $2.42 Million
54,188 Added 117.12%
100,456 $4.34 Million
Q1 2020

May 15, 2020

BUY
$22.46 - $42.24 $1.04 Million - $1.95 Million
46,268 New
46,268 $1.54 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.